Chemokines and disease
The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Abstract
We examine here several diseases that are associated with inappropriate activation of the chemokine network. Detailed comment has been restricted to pathological states for which there are compelling data either from clinical observations or animal models. These include cardiovascular disease, allergic inflammatory disease, transplantation, neuroinflammation, cancer and HIV-associated disease. Discussion focuses on therapeutic directions in which the rapidly evolving chemokine field appears to be headed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, among the 30 enriched terms, two GO-terms are T-cell chemotaxis and cell–cell adhesion which play a critical role in the immune system (Springer, 1990; Gerard and Rollins, 2001; Bach et al., 2007).”
From Identification of Candidate Signature Genes and Key Regulators Associated With Trypanotolerance in the Sheko Breed (2019) · cites this paper as Gerard and Rollins, 2001
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909 · Cited by 1,984
Self-citationBoring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,575
Self-citationQin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1422 · Cited by 1,359
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27348 · Cited by 1,222
Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.
Leek, R., Lewis, C. E., Whitehouse, R. M., Greenall, M. J., Clarke, J., & Harris, A. L. (1996) · PubMed · Cited by 1,187
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., et al. (1996) · Nature · doi:10.1038/384179a0 · Cited by 1,167
Self-citationBoring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese, R. V., Broxmeyer, H. E., & Charo, I. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119798 · Cited by 1,096
Research works printed but not linked: 3
- Wedderburn, L. R., Robinson, N., Patel, A., Varsani, H. & Woo, P. Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum. 43, 765–774 (2000). · doi:10.1002/1529-0131(200004)43:4<765::aid-anr7>3.0.co;2-b
- Bashford, E. F. in Scientific Reports on the Investigations of the ICRF (eds Bashford, E. F., Murray, J. A. & Cramer, W.) (ICRF, London, 1905).
- Russell, B. R. G. The nature of resistance to the inoculation of cancer. Sci. Rep. ICRF 3, 341–358 (1908).
Cited by
Inflammatory responses and inflammation-associated diseases in organs
Chen, L., Deng, H., Cui, H., Fang, J., Zuo, Z., Deng, J., Li, Y., Wang, X., & Zhao, L. (2018) · Oncotarget · doi:10.18632/oncotarget.23208 · Cited by 5,143
Foreign body reaction to biomaterials
Anderson, J. M., Rodriguez, A., & Chang, D. T. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2007.11.004 · Cited by 5,138
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
Molecular characterization of the tumor microenvironment in breast cancer
Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.010 · Cited by 1,299
Dong, Y., & Benveniste, E. N. (2001) · Glia · doi:10.1002/glia.1107 · Cited by 1,293
C hemokines in I nnate and A daptive H ost D efense : Basic Chemokinese Grammar for Immune Cells
Rot, A., & von Andrian, U. H. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104543 · Cited by 1,215
Monocyte chemoattractant protein 1 in obesity and insulin resistance
Sartipy, P., & Loskutoff, D. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133870100 · Cited by 1,201
Tsou, C.-L., Peters, W., Si, Y., Slaymaker, S., Aslanian, A. M., Weisberg, S. P., Mack, M., & Charo, I. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29919 · Cited by 1,152
“Introduction Recruitment of monocytes to sites of inflammation is critical for host defense and is regulated by chemokines (1, 2).”
Astrocyte Crosstalk in CNS Inflammation
Linnerbauer, M., Wheeler, M. A., & Quintana, F. J. (2020) · Neuron · doi:10.1016/j.neuron.2020.08.012 · Cited by 989
“While CCL2 and CXCL10 represent signaling molecules through which astrocytes control the recruitment of monocytes, macrophages and T cells to the CNS (Gerard and Rollins, 2001), astrocytederived CXCL12 regulates the recruitment of pathogenic B-cells (Krumbholz et al.”
BackgroundEotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis
Blanchard, C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26679 · Cited by 870
Chemokines: multiple levels of leukocyte migration control☆
Moser, B., Wolf, M., Walz, A., & Loetscher, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.12.005 · Cited by 860
Chemokines: immunology's high impact factors
Mackay, C. R. (2001) · Nature Immunology · doi:10.1038/84298 · Cited by 845
Regulation of the Chemokine Receptor CXCR4 by Hypoxia
Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S. K., Doni, A., Rapisarda, A., Bernasconi, S., Saccani, S., Nebuloni, M., Vago, L., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030267 · Cited by 841
Chemokine:Receptor Structure, Interactions, and Antagonism
Allen, S. J., Crown, S. E., & Handel, T. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090529 · Cited by 839
Chemokines in the Pathogenesis of Vascular Disease
Charo, I. F., & Taubman, M. B. (2004) · Circulation Research · doi:10.1161/01.res.0000146672.10582.17 · Cited by 752
The phagocytes: neutrophils and monocytes
Dale, D. C., Boxer, L., & Liles, W. C. (2008) · Blood · doi:10.1182/blood-2007-12-077917 · Cited by 740
Rola, R., Raber, J., Rizk, A., Otsuka, S., VandenBerg, S. R., Morhardt, D. R., & Fike, J. R. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.005 · Cited by 714
Structure of the CCR5 Chemokine Receptor–HIV Entry Inhibitor Maraviroc Complex
Tan, Q., Zhu, Y., Li, J., Chen, Z., Han, G. W., Kufareva, I., Li, T., Ma, L., Fenalti, G., Li, J., et al. (2013) · Science · doi:10.1126/science.1241475 · Cited by 712
Chemokines in pathology and medicine
Baggiolini, M. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00867.x · Cited by 677
Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1
McQuibban, G. A., Butler, G. S., Gong, J.-H., Bendall, L., Power, C., Clark-Lewis, I., & Overall, C. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107736200 · Cited by 655
The immune system and cardiac repair
FRANGOGIANNIS, N. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.06.007 · Cited by 641
Ramesh, G., MacLean, A. G., & Philipp, M. T. (2013) · Mediators of Inflammation · doi:10.1155/2013/480739 · Cited by 639
“The chemokine CCL2 reported in Lyme neuroborreliosis is of particular importance in mediating inflammation in neurodegenerative diseases [165, 166].”
BackgroundStructure, Function, and Inhibition of Chemokines
Fernandez, E. J., & Lolis, E. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.091901.115838 · Cited by 609
Chemokines and Their Receptors: Drug Targets in Immunity and Inflammation
Viola, A., & Luster, A. D. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.121806.154841 · Cited by 583
MCP-1: Chemoattractant with a role beyond immunity: A review
Yadav, A., Saini, V., & Arora, S. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.006 · Cited by 488
Immunologic messenger molecules: Cytokines, interferons, and chemokines
Commins, S. P., Borish, L., & Steinke, J. W. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.07.008 · Cited by 479
Granulocyte Macrophage Colony-Stimulating Factor
McQualter, J. L., Darwiche, R., Ewing, C., Onuki, M., Kay, T. W., Hamilton, J. A., Reid, H. H., & Bernard, C. C. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.7.873 · Cited by 477
Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4
Hatse, S., Princen, K., Bridger, G., De Clercq, E., & Schols, D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03143-5 · Cited by 448
Chemokines and chemokine receptors: their manifold roles in homeostasis and disease.
Le, Y., Zhou, Y., Iribarren, P., & Wang, J. (2004) · PubMed · Cited by 446
Expression of CXCR4 and CXCL12 (SDF‐1) in human prostate cancers (PCa) in vivo
Sun, Y., Wang, J., Shelburne, C. E., Lopatin, D. E., Chinnaiyan, A. M., Rubin, M. A., Pienta, K. J., & Taichman, R. S. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10522 · Cited by 443
The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases
Conductier, G., Blondeau, N., Guyon, A., Nahon, J.-L., & Rovère, C. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.010 · Cited by 404
Cellular and Molecular Dynamics in the Foreign Body Reaction
Luttikhuizen, D. T., Harmsen, M. C., & Luyn, M. J. A. V. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.1955 · Cited by 396
Chemokines: key players in innate and adaptive immunity
Esche, C., Stellato, C., & Beck, L. A. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23841.x · Cited by 385
Chemokine receptor CCR5: insights into structure, function, and regulation
Oppermann, M. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.04.007 · Cited by 376
CXCR4 Is a Major Chemokine Receptor on Glioma Cells and Mediates Their Survival
Zhou, Y., Larsen, P. H., Hao, C., & Yong, V. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206222200 · Cited by 363
Role of cytokines and chemokines in non-alcoholic fatty liver disease
Braunersreuther, V. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i8.727 · Cited by 362
Lohmann, N., Schirmer, L., Atallah, P., Wandel, E., Ferrer, R. A., Werner, C., Simon, J. C., Franz, S., & Freudenberg, U. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai9044 · Cited by 351
Bertini, R., Allegretti, M., Bizzarri, C., Moriconi, A., Locati, M., Zampella, G., Cervellera, M. N., Di Cioccio, V., Cesta, M. C., Galliera, E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402090101 · Cited by 333
Chemokines, chemokine receptors, and cancer metastasis
Kakinuma, T., & Hwang, S. T. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105633 · Cited by 331
Chemokines in asthma: Cooperative interaction between chemokines and IL-13
Rosenwasser, L. J., Zimmermann, N., Hershey, G. K., Foster, P. S., & Rothenberg, M. E. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.139 · Cited by 331
Fractalkine in Vascular Biology: From Basic Research to Clinical Disease
Umehara, H., Bloom, E. T., Okazaki, T., Nagano, Y., Yoshie, O., & Imai, T. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000095360.62479.1f · Cited by 319
Overcoming hurdles in developing successful drugs targeting chemokine receptors
Schall, T. J., & Proudfoot, A. E. I. (2011) · Nature Reviews Immunology · doi:10.1038/nri2972 · Cited by 318
Platelet chemokines and chemokine receptors, linking hemostasis, inflammation, and host defense
GEAR, A. R. L., & CAMERINI, D. (2003) · Microcirculation · doi:10.1038/sj.mn.7800198 · Cited by 317
“Atherosclerosis is an inflammatory disease in which platelets (61,134), their chemokines, and chemokine receptors play key roles.”
BackgroundInflammation after Ischemic Stroke: The Role of Leukocytes and Glial Cells
Kim, J. Y., Park, J., Chang, J. Y., Kim, S.-H., & Lee, J. E. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.5.241 · Cited by 309
Chemokine receptor antagonists: overcoming developmental hurdles
Horuk, R. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2734 · Cited by 303
Regulation of pulmonary fibrosis by chemokine receptor CXCR3
Jiang, D., Liang, J., Hodge, J., Lu, B., Zhu, Z., Yu, S., Fan, J., Gao, Y., Yin, Z., Homer, R., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci16861 · Cited by 303
Self-citationWong, M.-L., Dong, C., Maestre-Mesa, J., & Licinio, J. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.59 · Cited by 295
Chemokine receptors: signposts to brain development and disease
Tran, P. B., & Miller, R. J. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1116 · Cited by 295
Cardiac Oxidative Stress and Inflammatory Cytokines Response after Myocardial Infarction
Neri, M., Fineschi, V., Paolo, M., Pomara, C., Riezzo, I., Turillazzi, E., & Cerretani, D. (2015) · Current Vascular Pharmacology · doi:10.2174/15701611113119990003 · Cited by 294
Garlet, G. P., Martins, W., Ferreira, B. R., Milanezi, C. M., & Silva, J. S. (2003) · Journal of Periodontal Research · doi:10.1034/j.1600-0765.2003.02012.x · Cited by 293
Nedoszytko, B., Sokołowska-Wojdyło, M., Ruckemann-Dziurdzińska, K., Roszkiewicz, J., & Nowicki, R. J. (2014) · Advances in Dermatology and Allergology · doi:10.5114/pdia.2014.40920 · Cited by 292
T cell migration in rheumatoid arthritis
Mellado, M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00384 · Cited by 291
Nitcheu, J., Bonduelle, O., Combadiere, C., Tefit, M., Seilhean, D., Mazier, D., & Combadiere, B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.2221 · Cited by 290
The Mechanistic Basis of Infarct Healing
Frangogiannis, N. G. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1907 · Cited by 288
Phosphoinositide 3-Kinase γ Is an Essential Amplifier of Mast Cell Function
Laffargue, M., Calvez, R., Finan, P., Trifilieff, A., Barbier, M., Altruda, F., Hirsch, E., & Wymann, M. P. (2002) · Immunity · doi:10.1016/s1074-7613(02)00282-0 · Cited by 286
Chemokines in ischemia and reperfusion
Frangogiannis, N. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-01-0022 · Cited by 276
Mechanisms of Regulation of the Chemokine-Receptor Network
Stone, M., Hayward, J., Huang, C., E. Huma, Z., & Sanchez, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020342 · Cited by 275
Physical Exercise Inhibits Inflammation and Microglial Activation
Mee-inta, O., Zhao, Z.-W., & Kuo, Y.-M. (2019) · Cells · doi:10.3390/cells8070691 · Cited by 268
Inflammatory Responses in Brain Ischemia
Kawabori, M., & Yenari, M. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150209154036 · Cited by 262
A SAGE (serial analysis of gene expression) view of breast tumor progression.
PORTER, D. A., Krop, I. E., Nasser, S. M., Sgroi, D. C., Kaelin, C. M., Marks, J. R., Riggins, G. J., & Polyák, K. (2001) · PubMed · Cited by 262
Zhou, L., Azfer, A., Niu, J., Graham, S., Choudhury, M., Adamski, F. M., Younce, C., Binkley, P. F., & Kolattukudy, P. E. (2006) · Circulation Research · doi:10.1161/01.res.0000220106.64661.71 · Cited by 260
Chemokines in Vascular Dysfunction and Remodeling
Schober, A. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.161224 · Cited by 257
Impact of Monocyte Chemoattractant Protein-1 Deficiency on Cerebral Aneurysm Formation
Aoki, T., Kataoka, H., Ishibashi, R., Nozaki, K., Egashira, K., & Hashimoto, N. (2009) · Stroke · doi:10.1161/strokeaha.108.532556 · Cited by 257
Lorenz, P., Ruschpler, P., Koczan, D., Stiehl, P., & Thiesen, H. (2003) · PROTEOMICS · doi:10.1002/pmic.200300412 · Cited by 257
Inoue, S., Egashira, K., Ni, W., Kitamoto, S., Usui, M., Otani, K., Ishibashi, M., Hiasa, K.-I., Nishida, K.-I., & Takeshita, A. (2002) · Circulation · doi:10.1161/01.cir.0000038140.80105.ad · Cited by 256
Acute Inflammation in Tissue Healing
Soliman, A. M., & Barreda, D. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010641 · Cited by 254
Human Hepatic Stellate Cells Express CCR5 and RANTES to Induce Proliferation and Migration
Schwabe, R. F., Bataller, R., & Brenner, D. A. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00215.2003 · Cited by 252
Barnes, B. J., Kellum, M. J., Field, A. E., & Pitha, P. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.16.5721-5740.2002 · Cited by 251
The epithelium in idiopathic pulmonary fibrosis: breaking the barrier
Camelo, A., Dunmore, R., Sleeman, M. A., & Clarke, D. L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00173 · Cited by 250
Innate Inflammatory Responses in Stroke: Mechanisms and Potential Therapeutic Targets
Kim, J. Y., Kawabori, M., & Yenari, M. A. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131228205146 · Cited by 250
Pope, S. M., Zimmermann, N., Stringer, K. F., Karow, M. L., & Rothenberg, M. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5341 · Cited by 250
Fractalkine/CX3CL1: A Potential New Target for Inflammatory Diseases
Jones, B. A., Beamer, M., & Ahmed, S. (2010) · Molecular Interventions · doi:10.1124/mi.10.5.3 · Cited by 249
Chemokines in rapid leukocyte adhesion triggering and migration
Johnston, B., & Butcher, E. C. (2002) · Seminars in Immunology · doi:10.1006/smim.2001.0345 · Cited by 247
CD4+ T Cells Mediate Abscess Formation in Intra-abdominal Sepsis by an IL-17-Dependent Mechanism
Chung, D. R., Kasper, D. L., Panzo, R. J., Chtinis, T., Grusby, M. J., Sayegh, M. H., & Tzianabos, A. O. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.1958 · Cited by 246
CXCR4–CCR5: A couple modulating T cell functions
Contento, R. L., Molon, B., Boularan, C., Pozzan, T., Manes, S., Marullo, S., & Viola, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804286105 · Cited by 242
Chemokines, inflammation and Trypanosoma cruzi infection
Teixeira, M. M., Gazzinelli, R. T., & Silva, J. S. (2002) · Trends in Parasitology · doi:10.1016/s1471-4922(02)02283-3 · Cited by 240
CCR6 is required for IL-23–induced psoriasis-like inflammation in mice
Hedrick, M. N., Lonsdorf, A. S., Shirakawa, A.-K., Lee, C.-C. R., Liao, F., Singh, S. P., Zhang, H. H., Grinberg, A., Love, P. E., Hwang, S. T., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37378 · Cited by 238
Inflammatory Cell Migration into the Central Nervous System: A Few New Twists on an Old Tale
Man, S., Ubogu, E. E., & Ransohoff, R. M. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00067.x · Cited by 235
Innate immunity in cystic fibrosis lung disease
Hartl, D., Gaggar, A., Bruscia, E., Hector, A., Marcos, V., Jung, A., Greene, C., McElvaney, G., Mall, M., & Döring, G. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.07.003 · Cited by 230
“Leukocyte transmigration into the extravascular space represents a multi-step process, involving rolling, activation, adhesion and diapedesis, requiring the concerted action of integrins, selectins and chemokines [82–84].”
BackgroundIshibashi, M., Hiasa, K.-I., Zhao, Q., Inoue, S., Ohtani, K., Kitamoto, S., Tsuchihashi, M., Sugaya, T., Charo, I. F., Kura, S., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000126924.23467.a3 · Cited by 230
Haringman, J. J., Smeets, T. J. M., Reinders-Blankert, P., & Tak, P. P. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.037176 · Cited by 227
Chen, X., Yang, L., Zhang, N., Turpin, J. A., Buckheit, R. W., Osterling, C., Oppenheim, J. J., & Howard, O. M. Z. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2810-2816.2003 · Cited by 225
“Chemokine antagonists with low molecular weights and high levels of bioavailability may have much higher therapeutic potential than steroids in certain disease states, with minimal side effects (15).”
BackgroundCCR6-CCL20 axis as a therapeutic target for autoimmune diseases
Meitei, H. T., Jadhav, N., & Lal, G. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102846 · Cited by 223
Role of the CXCL12/CXCR4 Axis in Peritoneal Carcinomatosis of Gastric Cancer
Yasumoto, K., Koizumi, K., Kawashima, A., Saitoh, Y., Arita, Y., Shinohara, K., Minami, T., Nakayama, T., Sakurai, H., Takahashi, Y., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3393 · Cited by 221
Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases
Bose, S., & Cho, J. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0161-z · Cited by 220
Li, B.-H., Garstka, M. A., & Li, Z.-F. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2019.11.014 · Cited by 220
Chemokines and Glial Cells: A Complex Network in the Central Nervous System
Ambrosini, E., & Aloisi, F. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000021246.96864.89 · Cited by 218
SDF-1α as a therapeutic stem cell homing factor in myocardial infarction
Ghadge, S. K., Mühlstedt, S., Özcelik, C., & Bader, M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.011 · Cited by 218
Oyajobi, B. O., Franchin, G., Williams, P. J., Pulkrabek, D., Gupta, A., Munoz, S., Grubbs, B., Zhao, M., Chen, D., Sherry, B., et al. (2003) · Blood · doi:10.1182/blood-2002-12-3905 · Cited by 215
Chemokines in liver inflammation and fibrosis
Marra, F. (2002) · Frontiers in Bioscience · doi:10.2741/a887 · Cited by 214
Xu, X.-E., Liu, L., Wang, Y.-C., Wang, C.-T., Zheng, Q., Liu, Q.-X., Li, Z.-F., Bai, X.-J., & Liu, X.-H. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.05.038 · Cited by 211
Peng, Y., He, D., Ge, X., Lu, Y., Chai, Y., Zhang, Y., Mao, Z., Luo, G., Deng, J., & Zhang, Y. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.02.006 · Cited by 211
Valenzuela-Fernaéndez, A., Planchenault, T., Baleux, F., Staropoli, I., Le-Barillec, K., Leduc, D., Delaunay, T., Lazarini, F., Virelizier, J.-L., Chignard, M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111388200 · Cited by 210
Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling
Zhan, Y. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24403 · Cited by 209
Schutyser, E., Struyf, S., Proost, P., Opdenakker, G., Laureys, G., Verhasselt, B., Peperstraete, L., Van de Putte, I., Saccani, A., Allavena, P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112275200 · Cited by 208
Promiscuous drugs compared to selective drugs (promiscuity can be a virtue)
Mencher, S. K., & Wang, L. G. (2005) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-5-3 · Cited by 206
Sadir, R., Imberty, A., Baleux, F., & Lortat-Jacob, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405392200 · Cited by 205
Chemokines in homeostasis and diseases
Chen, K., Bao, Z., Tang, P., Gong, W., Yoshimura, T., & Wang, J. M. (2018) · Cellular & Molecular Immunology · doi:10.1038/cmi.2017.134 · Cited by 201
Oxidative damage pathways in relation to normal tissue injury
Zhao, W., Diz, D. I., & Robbins, M. E. (2007) · The British Journal of Radiology · doi:10.1259/bjr/18237646 · Cited by 201
Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies
Kufareva, I., Salanga, C. L., & Handel, T. M. (2015) · Immunology & Cell Biology · doi:10.1038/icb.2015.15 · Cited by 200
Metadata
- Authors
- Gerard, C., & Rollins, B. J.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Gerard, Craig
- Rollins, Barrett J.
- ORCID
- Rollins, Barrett J.
- Venue
- Nature Immunology
- Published
- 2001-02
- Volume
- 2
- Issue
- 2
- Pages
- 108-115
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1602000691
- Cited by
- 1,357
- References
- 119
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 19 · 2023: 28 · 2022: 23 · 2021: 29 · 2020: 27 · 2019: 40 · 2018: 24 · 2017: 38 · 2016: 32 · 2015: 51 · 2014: 40 · 2013: 75 · 2012: 48
- FWCI
- 10.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- chemokines, chemokine signaling, cardiovascular disease, allergic inflammation, transplantation, neuroinflammation, cancer, HIV-associated diseases, chemokine-targeted therapy
- MeSH terms
- Animals, Arthritis, Rheumatoid, Asthma, Disease Models, Animal, Encephalomyelitis, Autoimmune, Experimental, Humans, Multiple Sclerosis, Neoplasms, Transplantation Immunology, Transplantation, Homologous, Vascular Diseases, HIV Infections, Chemokines, Receptors, Chemokine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.